Hodgkin disease-like posttransplantation lymphoproliferative disorder of donor origin in a renal allograft recipient

American Journal of Kidney Diseases

Volumn 47, Issue 3, 2006, Pages

  Schlieper, Georg ^a   Kurschat, Christine ^b   Donner, Andreas ^b   Huckenbeck, Wolfgang ^b   Rüdiger, Thomas ^b   Sandmann, Wilhelm ^b   Grabensee, Bernd ^b   Ivens, Katrin ^b   Heering, Peter ^b  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b NONE

Author keywords

DNA fingerprinting; Epstein Barr virus; Posttransplantation lymphoproliferative disorder; Retransplantation

Indexed keywords

CD15 ANTIGEN; CD20 ANTIGEN; CYCLOSPORIN A; PREDNISOLONE;

ADOLESCENT; ANAMNESIS; ARTICLE; CASE REPORT; DNA FINGERPRINTING; ECHOGRAPHY; EPSTEIN BARR VIRUS; HISTOLOGY; HODGKIN DISEASE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; LYMPHOPROLIFERATIVE DISEASE; MALE; NEPHRECTOMY; ORGAN DONOR; REED STERNBERG CELL; RETRANSPLANTATION;

ADOLESCENT; HODGKIN DISEASE; HUMANS; KIDNEY TRANSPLANTATION; LYMPHOPROLIFERATIVE DISORDERS; MALE; TISSUE DONORS;

EID: 32844458665     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2005.11.022     Document Type: Article

References (29)

1. I. Penn, W. Hammond, L. Brettschneider, T.E. Starzl Malignant lymphomas in transplantation patients Transplant Proc 1 1969 106 112
2. A.H. Wilkinson, J.L. Smith, L.G. Hunsicker Increased frequency of posttransplant lymphomas in patients treated with cyclosporine, azathioprine, and prednisone Transplantation 47 1989 293 296
3. T. Beveridge, P. Krupp, C. McKibbin Lymphomas and lymphoproliferative lesions developing under cyclosporin therapy Lancet 1 1984 788 (short report)
4. D.W. Hanto, G. Frizzera, K.J. Gajl-Peczalska, R.L. Simmons Epstein-Barr virus, immunodeficiency, and B cell lymphoproliferation Transplantation 39 1985 461 472
5. B. Hjelle, M. Evans-Holm, T.S. Yen, M. Garovoy, M. Guis, J.C. Edman A poorly differentiated lymphoma of donor origin in a renal allograft recipient Transplantation 47 1989 945 948
6. I.O. Ng, T.W. Shek, S.N. Thung Microsatellite analysis in post-transplantation lymphoproliferative disorder to determine donor/recipient origin Mod Pathol 13 2000 1180 1185
7. S. Caillard, E. Pencreach, L. Braun Simultaneous development of lymphoma in recipients of renal transplants from a single donor Donor origin confirmed by human leukocyte antigen staining and microsatellite analysis Transplantation 79 2005 79 84
8. M.L. Gulley, L.J. Swinnen, K.T. Plaisance Jr, C. Schnell, T.M. Grogan, B.G. Schneider Tumor origin and CD20 expression in posttransplant lymphoproliferative disorder occurring in solid organ transplant recipients Implications for immune-based therapy Transplantation 76 2003 959 964
9. A.M. Gassel, E. Westphal, M.L. Hansmann, G. Leimenstoll, H.J. Gassel Malignant lymphoma of donor origin after renal transplantation A case report Hum Pathol 22 1991 1291 1293
10. G. Meduri, L. Fromentin, A. Vieillefond, D. Fries Donor-related non-Hodgkin's lymphoma in a renal allograft recipient Transplant Proc 23 1991 2649 (short report)
11. T. Srivastava, D.L. Zwick, P.G. Rothberg, B.A. Warady Posttransplant lymphoproliferative disorder in pediatric renal transplantation Pediatr Nephrol 13 1999 748 754
12. S. Ranganathan, S. Webber, S. Ahuja, R. Jaffe Hodgkin-like posttransplant lymphoproliferative disorder in children Does it differ from posttransplant Hodgkin lymphoma? Pediatr Dev Pathol 7 2004 348 360
13. G. Opelz, B. Dohler Lymphomas after solid organ transplantation A collaborative transplant study report Am J Transplant 4 2004 222 230
14. S. Boubenider, C. Hiesse, C. Goupy, F. Kriaa, S. Marchand, B. Charpentier Incidence and consequences of post-transplantation lymphoproliferative disorders J Nephrol 10 1997 136 145
15. C. Jones, B. Bleau, N. Buskard Simultaneous development of diffuse immunoblastic lymphoma in recipients of renal transplants from a single cadaver donor Transmission of Epstein-Barr virus and triggering by OKT3 Am J Kidney Dis 23 1994 130 134
16. S.A. Birkeland, H.K. Andersen, S.J. Hamilton-Dutoit Preventing acute rejection, Epstein-Barr virus infection, and posttransplant lymphoproliferative disorders after kidney transplantation Use of acyclovir and mycophenolate mofetil in a steroid-free immunosuppressive protocol Transplantation 67 1999 1209 1214
17. S. Ranganathan, R. Jaffe Is there a difference between Hodgkin's disease and a Hodgkin's-like post-transplant lymphoproliferative disorder, and why should that be of any interest? Pediatr Transplant 8 2004 6 8
18. R. Shroff, L. Rees The post-transplant lymphoproliferative disorder - A literature review Pediatr Nephrol 19 2004 369 377
19. L.J. Swinnen, G.M. Mullen, T.J. Carr, M.R. Costanzo, R.I. Fisher Aggressive treatment for postcardiac transplant lymphoproliferation Blood 86 1995 3333 3340
20. J.F. Buell, T.G. Gross, M.J. Hanaway Chemotherapy for posttransplant lymphoproliferative disorder The Israel Penn International Transplant Tumor Registry experience Transplant Proc 37 2005 956 957
21. A.H. Blaes, B.A. Peterson, N. Bartlett, D.L. Dunn, V.A. Morrison Rituximab therapy is effective for posttransplant lymphoproliferative disorders after solid organ transplantation Cancer 104 2005 1661 1667
22. B. Savoldo, C.M. Rooney, R.E. Quiros-Tejeira Cellular immunity to Epstein-Barr virus in liver transplant recipients treated with rituximab for post-transplant lymphoproliferative disease Am J Transplant 5 2005 566 572
23. M. Majewski, M. Korecka, P. Kossev The immunosuppressive macrolide RAD inhibits growth of human Epstein-Barr virus-transformed B lymphocytes in vitro and in vivo A potential approach to prevention and treatment of posttransplant lymphoproliferative disorders Proc Natl Acad Sci U S A 97 2000 4285 4290
24. R.R. Nepomuceno, C.E. Balatoni, Y. Natkunam, A.L. Snow, S.M. Krams, O.M. Martinez Rapamycin inhibits the interleukin 10 signal transduction pathway and the growth of Epstein Barr virus B-cell lymphomas Cancer Res 63 2003 4472 4480
25. J.F. Buell, T.G. Gross, M.J. Hanaway Posttransplant lymphoproliferative disorder Significance of central nervous system involvement Transplant Proc 37 2005 954 955
26. J. Trofe, J.F. Buell, T.M. Beebe Analysis of factors that influence survival with post-transplant lymphoproliferative disorder in renal transplant recipients The Israel Penn International Transplant Tumor Registry experience Am J Transplant 5 2005 775 780
27. B. Petit, Y. Le Meur, A. Jaccard Influence of host-recipient origin on clinical aspects of posttransplantation lymphoproliferative disorders in kidney transplantation Transplantation 73 2002 265 271
28. S.A. Birkeland, S. Hamilton-Dutoit, K. Bendtzen Long-term follow-up of kidney transplant patients with posttransplant lymphoproliferative disorder Duration of posttransplant lymphoproliferative disorder-induced operational graft tolerance, interleukin-18 course, and results of retransplantation Transplantation 76 2003 153 158
29. A. Karras, E. Thervet, Y.L. Meur, V. Baudet-Bonneville, M. Kessler, C. Legendre Successful renal retransplantation after post-transplant lymphoproliferative disease Am J Transplant 4 2004 1904 1909